AUPH - Aurinia Pharmaceuticals gains on speculation of other potential bidder interest

Aurinia Pharmaceuticals (NASDAQ:AUPH) rose 4.4% after speculation that several other pharma companies may be looking at the company. GlaxoSmithKline (NYSE:GSK), Roche (OTCQX:RHHBY) and Otsuka Pharmaceuticals (OTCPK:OTSKF)  are speculated are speculated to reviewing a potential bid for Aurinia, according to a Betaville "rare" alert. There was speculation that Aurinia (AUPH) was offered $42/share from one party and another bid $44.50, according to the report. The report comes after Bloomberg last week said that Bristol Myers Squibb may be interested in making a bid for Aurinia.

For further details see:

Aurinia Pharmaceuticals gains on speculation of other potential bidder interest